About the position:

  1. Our mission is to discover novel small-molecule degraders to treat cancer and other human diseases with serious unmet medical needs.
  2. We are seeking a highly motivated scientist with research experience in structural biology and biophysics.
  3. To join a multi-disciplinary drug discovery team based within Dundee’s School of Life Sciences.
  4. Under the auspices of a new Protein Degradation Centre.
  5. The team is engaged in an exciting collaboration on proteolysis-targeting chimeras
  6. (PROTAC) drug discovery between the laboratories of Professor Alessio Ciulli (http://www.lifesci.dundee.ac.uk/groups/alessio-ciulli) and Boehringer Ingelheim.

Eligibility Criteria:

  • Doctoral in structural biology, biophysics, biochemistry, chemical biology or a related discipline.
  • Highly experienced in molecular biology (construct design, cloning etc.), protein expression, purification and characterisation
  • Strong background in structural biology and biophysics, with an emphasis on structure-based drug design.
  • Proven expertise with biophysical techniques and assays to study protein-ligand binding and protein-protein interactions
  • Experience with either protein crystallization, X-ray data collection (in-house and at synchrotrons), structure solution and model refinement, or protein NMR spectroscopy, or cryo-EM.
  • Strong interpersonal, communication and presentation skills.

How to Apply:

Quick Overview:
Organization University of Dundee
Type of position Postdoctoral
Country UK
Subject areas Structural biology, biophysics, biochemistry, chemical biology
Deadline August 30,2020

Leave a Reply

Your email address will not be published. Required fields are marked *